e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Infection, inflammation and destruction
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inter-observer variability in CT evaluation of effect of azithromycin therapy in non-cystic fibrosis bronchiectatic patients
J. Soens, P. Goeminne, L. Dupont, F. De Keyzer, W. De Wever (Belgium)
Source:
Annual Congress 2010 - Infection, inflammation and destruction
Session:
Infection, inflammation and destruction
Session type:
Thematic Poster Session
Number:
4115
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Soens, P. Goeminne, L. Dupont, F. De Keyzer, W. De Wever (Belgium). Inter-observer variability in CT evaluation of effect of azithromycin therapy in non-cystic fibrosis bronchiectatic patients. Eur Respir J 2010; 36: Suppl. 54, 4115
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Retrospective analysis of CT before and after azithromycin therapy in non-cystic fibrosis bronchiectasis using a modified Brody-score
Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Year: 2010
Aerozolized colistin therapy in non-cystic fibrosis patients with bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 266s
Year: 2001
Effects of long-term azithromycin treatment in patients with non-cystic fibrosis stable bronchiectasis
Source: Annual Congress 2007 - Infectious lung and pleural diseases
Year: 2007
The effect of emphysema in patients with idiopathic pulmonary fibrosis; evaluation using quantitative CT analysis
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Free-breathing MRI for monitoring ventilation changes following antibiotic treatment of pulmonary exacerbations in paediatric cystic fibrosis
Source: Eur Respir J, 57 (4) 2003104; 10.1183/13993003.03104-2020
Year: 2021
HRCT features in patients with severe asthma and non-cystic fibrosis bronchiectasis.
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020
Physical activity evaluation in non-cystic fibrosis bronchiectasis patients
Source: International Congress 2017 – Assessing pulmonary and extra-pulmonary function in chronic disease
Year: 2017
The effect of maintenance azithromycin on radiological features in patients with bronchiectasis
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
Evaluation of bone strength by quantitative ultrasound in children with non-cystic fibrosis bronchiectasis
Source: Eur Respir J 2002; 20: Suppl. 38, 339s
Year: 2002
Applicative value of chest HRCT for bronchiectasis evaluating in pulmonary infection with pseudomonas aeruginosa in patients with cystic fibrosis
Source: International Congress 2016 – Mixed-up imaging of various chest diseases
Year: 2016
Longitudinal structural changes using MDCT in patients with combined pulmonary fibrosis with emphysema
Source: Virtual Congress 2021 – Imaging
Year: 2021
Voxelwise lung pattern transition scores on HRCT images and their association with symptoms in patients with idiopathic pulmonary fibrosis
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Year: 2017
Comparison of emphysema in patients with COPD before and after treatment of tiotropium by quantitative assessment by HRCT
Source: Eur Respir J 2007; 30: Suppl. 51, 619s
Year: 2007
Comparison of high resolution computerized tomography (HRCT) of the chest and pulmonary function testing in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis (CF) patients
Source: Eur Respir J 2004; 24: Suppl. 48, 387s
Year: 2004
Pulmonary arterial enlargement is a predictor of higher risk of exacerbations in non-cystic fibrosis bronchiectasis patients
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021
Effect of azithromycin on FEV1 and exacerbation frequency in adult non-cystic fibrosis bronchiectasis
Source: Eur Respir J 2007; 30: Suppl. 51, 528s
Year: 2007
Usefulness of long term treatment with azithromycin in patients with bronchiectasis (non cystic fibrosis)
Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections
Year: 2010
Relationship between the radiological pattern in the HRCT and
Pneumocystis jirovecii
colonization in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Unusual pathogens in respiratory infections
Year: 2010
18
FDG-PET imaging detects inflammatory changes in pediatric cystic fibrosis patients after treatment for a pulmonary exacerbation
Source: Annual Congress 2010 - Cystic fibrosis: new targets for therapy and impact of viral infections
Year: 2010
The role of lung ultrasonography in the assessment of idiopathic pulmonary fibrosis –correlation with HRCT finding
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept